Thursday, 26 October 2017

Live Cell Imaging Market by Technology, Application & Product | MarketsandMarkets

Live cell imaging involves the study of living cells though the use of images acquired from microscopes and high-content screening systems. It has become a popular analytical tool for elucidation of biological mechanisms and for the study of the dynamic functions of a cell”.
The live cell imaging market is segmented on the basis of products, technologies, applications, and regions. The global market was valued at $3.57 Billion in 2014 and is poised to grow at a CAGR of 8.8% during the forecasted period.

Driving Factors : 

Factors such as adoption of high-content screening techniques in drug discovery, rising incidence of cancer worldwide, and government funding in cell-based research are driving the growth of this market. Moreover, emerging Asian markets, adoption of high-content screening for primary screening, and increasing application of live cell imaging techniques in personalized medicine are likely to create huge opportunities for this market in the coming years.

Based on technologies, the live cell imaging market is segmented into fluorescence resonance energy transfer (FRET), fluorescence in situ hybridization (FISH), high-content analysis (HCA), fluorescence recovery after photobleaching (FRAP), ratiometric imaging, total internal reflection fluorescence microscopy (TRIF), multiphoton excitation microscopy (MPE), and other technologies. The fluorescence resonance energy transfer (FRET) segment accounted for the largest share of the market.

Regional Analysis : 

The global live cell imaging market is expected to reach $5.45 Billion by 2019 from $3.57 Billion in 2014, growing at a CAGR of 8.8% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the fastest rate during the forecast period.
Live Cell Imaging Market
Major players in the global market : 

Carl Zeiss AG (Germany), Leica Microsystems (Germany), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).


No comments:

Post a Comment